Tag: Brock Dahl
Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
English
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
For Marco Chung, group head of legal at CITIC Securities International, the choice for arbitration seat in China-related disputes is clear